This post was originally published on this site
Danaher (NYSE:DHR) will pay $24 per share in cash, a 2.7% premium to Abcam’s last closing price.
Abcam shares rose 3.9% higher on Friday after Reuters reported Danaher was in the lead to acquire the company.
Danaher, one of the world’s largest suppliers of diagnostic tools with a market value of $190 billion, has turned to dealmaking to expand in the sector. Abcam’s antibody and reagent solutions could help Danaher win more and bigger contracts with some customers.
